Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transition to tenecteplase is associated with shorter door-to-puncture times: a retrospective study from the Lone Star Stroke consortium TNK registry.

Frontiers in neurology·2026
Same author

Neurosurgical and prehospital timing in severe traumatic brain injury: Insights from the prospective Resuscitation Outcomes Consortium hypertonic saline trial.

The journal of trauma and acute care surgery·2026
Same author

Hospital Medicaid payer mix associated with inpatient mortality following traumatic brain injury.

The journal of trauma and acute care surgery·2026
Same author

Hypertension With High-Risk Features in Cryptogenic Stroke: An Exploratory Analysis of the ARCADIA Randomized Clinical Trial.

JAMA neurology·2026
Same author

Physiology-informed machine learning for patient-level surgical decision-making in severe traumatic brain injury: Multicenter model development with external validation.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026
Same author

Combination of Albumin and Cilostazol Improves Outcomes in a Rodent Model of Aneurysmal Subarachnoid Hemorrhage.

Neurocritical care·2026

Related Experiment Video

Updated: May 10, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Stroke-associated pneumonia: major advances and obstacles.

Yousef Hannawi1, Bashar Hannawi, Chethan P Venkatasubba Rao

  • 1Department of Neurology, Baylor College of Medicine, Houston, TX, USA. yousefhannawi @ yahoo.com

Cerebrovascular Diseases (Basel, Switzerland)
|June 6, 2013
PubMed
Summary

Stroke-associated pneumonia (SAP) is a significant complication after acute ischemic stroke, particularly in intensive care units (ICUs). Further research is needed to clarify its incidence and prognosis in these critical care settings.

More Related Videos

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

Related Experiment Videos

Last Updated: May 10, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia
13:45

A Precise Pathogen Delivery and Recovery System for Murine Models of Secondary Bacterial Pneumonia

Published on: September 21, 2019

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Infectious Diseases

Background:

  • Stroke-associated pneumonia (SAP) significantly increases morbidity, mortality, and healthcare costs following acute ischemic stroke.
  • The annual hospitalization cost for SAP in the US is approximately $459 million.
  • The incidence and prognosis of SAP specifically within intensive care unit (ICU) populations remain under-investigated.

Purpose of the Study:

  • To review the pathophysiology, microbiology, incidence, risk factors, outcomes, and prophylaxis of SAP.
  • To focus on studies conducted in intensive care units (ICUs).

Main Methods:

  • A comprehensive literature search was conducted on PubMed using terms 'pneumonia', 'neurology intensive unit', 'stroke', and 'pneumonia'.
  • Studies were excluded if they were non-English, case reports, or focused on chronic SAP.
  • Research articles were categorized based on their study setting: NICUs, MICUs, stroke units, mixed settings, or rehabilitation.

Main Results:

  • SAP incidence varied widely across settings: NICUs (4.1-56.6%), MICUs (17-50%), stroke units (3.9-44%), mixed studies (3.9-23.8%), and rehabilitation (3.2-11%).
  • Higher SAP incidence in ICUs is linked to mechanical ventilation, stroke severity, aspiration, and stroke-induced immunosuppression.
  • SAP was associated with increased short-term mortality (10.1-37.3% in mixed/stroke units) and worse functional outcomes, though mortality consistency varied in ICU studies due to heterogeneity and confounding factors.

Conclusions:

  • A unified definition and strict inclusion criteria are necessary for future prospective studies on SAP.
  • Long-term follow-up is crucial for accurately determining SAP incidence and prognosis, especially in ICU patients.
  • Standardized research approaches will improve understanding of SAP's impact and management in critical care.